Edition:
United States

Japan Tobacco Inc (2914.T)

2914.T on Tokyo Stock Exchange

3,815JPY
9 Dec 2016
Change (% chg)

¥35 (+0.93%)
Prev Close
¥3,780
Open
¥3,740
Day's High
¥3,828
Day's Low
¥3,735
Volume
5,671,100
Avg. Vol
4,175,164
52-wk High
¥4,850
52-wk Low
¥3,627

Select another date:

Tue, Nov 29 2016

UPDATE 1-Japan Tobacco shakes up management to spur global growth

LONDON, Nov 29 Japan Tobacco, the world's third-largest tobacco company, announced management changes on Tuesday designed to accelerate the growth of its international business, which is under pressure to join industry consolidation.

Japan Tobacco to roll out e-cigarette next year

LONDON Japan Tobacco aims to start selling its Ploom Tech tobacco-based electronic cigarette in cities across Japan next year, it said on Friday, as it fights to catch up with bigger rival Philip Morris in meeting the growing demand for "vaping" products.

CORRECTED-UPDATE 1-Japan Tobacco to roll out e-cigarette next year

LONDON, Sept 23 Japan Tobacco aims to start selling its Ploom Tech tobacco-based electronic cigarette in cities across Japan next year, it said on Friday, as it fights to catch up with bigger rival Philip Morris in meeting the growing demand for "vaping" products.

Japan Tobacco to roll out e-cigarette next year

LONDON, Sept 23 Japan Tobacco is aiming to start rolling out its Ploom Tech tobacco-based e-cigarette in cities across Japan next year, a senior executive said on Friday, as it fights to catch up to larger rival Philip Morris.

Electronic Marlboro sucks Japanese smokers away from Japan Tobacco

TOKYO Marlboro maker Philip Morris International says its e-cigarette has rapidly captured close to 3 percent of Japanese tobacco sales, making inroads into a market Japan Tobacco (JT) relies on for 40 percent of its profit.

Electronic Marlboro sucks Japanese smokers away from Japan Tobacco

* PMI says e-cigarette has 2.7 pct share in Japan tobacco market

BRIEF-Menlo Therapeutics signs license agreement with Japan Tobacco, Torii Pharma for NK-1 receptor antagonist

* Menlo Therapeutics signs exclusive license agreement with Japan Tobacco and Torii Pharmaceuticals for development and commercialization of NK-1 receptor antagonist in Japan

BRIEF-Japan Tobacco gets 40 pct stake in National Tobacco Enterprise Ethiopia S.C for $510 mln

* Says it got 40 percent stake in National Tobacco Enterprise Ethiopia S.C from Ethiopian government for $510 million

Select another date: